Hematopoietic Stem Cell TransplantationUnrelated DonorsHistocompatibility TestingGraft vs Host DiseaseTransplantation ConditioningTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationTransplantation, AutologousStem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTissue DonorsBone Marrow TransplantationTransplantation ChimeraTreatment OutcomeCord Blood Stem Cell TransplantationGraft SurvivalHematopoiesisMyeloablative AgonistsWhole-Body IrradiationHistocompatibilityHematopoietic Stem Cell MobilizationBusulfanAntigens, CD34Liver TransplantationChimerismRetrospective StudiesLeukemiaGraft vs Leukemia EffectRecurrenceCell DifferentiationBone Marrow CellsMesenchymal Stem Cell TransplantationImmunosuppressive AgentsHematologic DiseasesRemission InductionHLA AntigensCombined Modality TherapyHepatic Veno-Occlusive DiseaseMultiple MyelomaSiblingsCell LineageCell TransplantationVidarabineLeukemia, Myeloid, AcuteTime FactorsMyelodysplastic SyndromesStem Cell NicheSurvival RateEmbryonic Stem CellsGraft vs Tumor EffectKidney TransplantationTransplantation ImmunologyFlow CytometryDisease-Free SurvivalAdult Stem CellsSurvival AnalysisMelphalanMice, Inbred C57BLSevere Combined ImmunodeficiencyLiving DonorsLymphocyte TransfusionBone MarrowTransplantation, IsogeneicFetal BloodCyclophosphamideColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorSalvage TherapyCytomegalovirus InfectionsAntilymphocyte SerumBlood DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticDonor SelectionGraft RejectionFollow-Up StudiesT-LymphocytesLymphocyte DepletionAllograftsCells, CulturedAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsCell SeparationMesenchymal Stromal CellsPluripotent Stem CellsImmunosuppressionMultipotent Stem CellsCell ProliferationStem Cell FactorOpportunistic InfectionsLymphoma, Non-HodgkinImmunocompromised HostLymphoproliferative DisordersOrgan TransplantationTransplantationHeart TransplantationPrognosis